Harrow, Inc. Loans Payable, Noncurrent
Harrow, Inc. (HROW) had Loans Payable, Noncurrent of $708.00 thousand as of 2020-12-31, per its 10-Q filed 2021-11-09.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt and Lease Obligation › Long-Term Debt, Excluding Current Maturities › Notes and Loans, Noncurrent
us-gaap:LongTermLoansPayable · last filed 2021-11-09
- 2020-12-31: Loans Payable, Noncurrent $708.00K.
- 2020-09-30: Loans Payable, Noncurrent $829.00K.
- 2020-06-30: Loans Payable, Noncurrent $1.14M.
| Period end | Loans Payable, Noncurrent |
|---|---|
| 2020-12-31 | $708.00K 10-Q · filed 2021-11-09 |
| 2020-09-30 | $829.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $1.14M 10-Q · filed 2020-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |